Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on blood testing & biomarkers. Browse all Blood Testing & Biomarkers education
IL1B encodes interleukin-1 beta, one of the body's most powerful inflammatory signals. Small genetic differences in how much IL-1 beta a person produces can influence the intensity of inflammation across many tissues — from the stomach lining to the gums to blood vessels.
This article explains what IL1B does, which variants matter most, the conditions research has linked to them, and how understanding this pathway fits into a broader, provider-guided approach to your health.
What the IL1B gene does
Interleukin-1 beta is a cytokine — a chemical messenger the immune system uses to raise the alarm. When cells detect injury or infection, IL-1 beta drives fever, recruits immune cells, and amplifies the inflammatory cascade. It is essential in short bursts and damaging when it runs high for too long.
Because IL-1 beta is so potent, the body tightly regulates how much is made. Genetic variants in the IL1B gene and its neighbors influence that set point, shifting some people toward a more pro-inflammatory baseline.
The variants that matter most
Two IL1B variants are studied most often. rs16944 (also written -511 C/T) sits in the gene's promoter region and is associated with differences in IL-1 beta production. rs1143634 (+3954 C/T) lies within the gene and has been linked to higher inflammatory output in some studies.
A related gene, IL1RN, encodes the IL-1 receptor antagonist — the natural brake on this pathway. The balance between IL1B (the accelerator) and IL1RN (the brake) is often more informative than either variant alone.
Conditions research has linked to IL1B variants
The best-studied association is with gastric inflammation. In people infected with Helicobacter pylori, high-IL-1-beta IL1B genotypes have been associated in research with more intense stomach inflammation and, in some populations, elevated gastric cancer risk. The gene sets the inflammatory response; the bacterium supplies the trigger.
IL1B variants have also been examined in periodontitis (gum inflammation and bone loss), and in inflammatory contributions to cardiovascular and metabolic conditions. Across these, IL1B is a modifier of inflammatory intensity rather than a stand-alone cause.
What the research shows and doesn't
Associations between IL1B variants and disease are real but context-dependent. They tend to appear where there is also an environmental trigger — an infection, a chronic irritant, or a metabolic stressor — and they vary between populations. A high-inflammation genotype without a trigger often produces no visible effect.
This is why IL1B is best understood as one dial among many. It can raise or lower the volume of inflammation, but the song still depends on diet, infections, oral hygiene, smoking, and overall metabolic health.
What genetic insight offers here
Knowing your IL1B pathway tendencies will not diagnose or manage any condition, but it can add useful context. If you lean pro-inflammatory, that information can reinforce the value of addressing modifiable triggers and staying current with the screenings your provider recommends.
The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants that sit within inflammatory signaling pathways. It offers pathway-level context about your biology — not a diagnosis, and not a pharmacogenomic prediction. PlexusDx tells you about your biology; it does not tell you what to put in your body.
Managing the modifiable side
You cannot change your IL1B genotype, but much of what determines its impact is modifiable. Addressing an H. pylori infection with a provider, maintaining oral health, not smoking, and supporting metabolic health all influence how loudly this pathway speaks.
Genetics is a guide, not a guarantee. The most useful move is to bring pathway insight into a conversation with a qualified provider, who can weigh it against your symptoms, history, and any appropriate testing.
Frequently Asked Questions
What conditions are linked to IL1B gene variants?
Research has linked high-inflammation IL1B genotypes to more intense gastric inflammation with Helicobacter pylori infection, and in some populations to gastric cancer risk. IL1B variants have also been studied in periodontitis and in inflammatory contributions to cardiovascular and metabolic conditions, generally as a modifier rather than a direct cause.
Which IL1B variants are most studied?
The promoter variant rs16944 (-511 C/T) and the coding-region variant rs1143634 (+3954 C/T) are the two most studied IL1B variants, both associated with differences in interleukin-1 beta production. The IL1RN gene, which encodes the pathway's natural brake, is often assessed alongside them for a fuller picture.
Can I manage the effects of an IL1B variant?
You cannot change the genotype, but you can address the triggers that determine its impact. Treating an H. pylori infection with a provider, maintaining oral health, avoiding smoking, and supporting metabolic health all influence how strongly this inflammatory pathway is expressed in daily life.
Does genetic testing diagnose disease from IL1B variants?
No. Testing identifies the variants and places them in your inflammatory pathway, but it does not diagnose, treat, or manage any condition. Diagnosis requires clinical evaluation by a qualified healthcare provider, who can interpret genetic context alongside symptoms, infection status, and appropriate laboratory testing.
Want to understand your own inflammatory signaling at the genetic level? Explore the Precision Peptide Genetic Test to see how your DNA shapes these biological pathways — insight you can review with your healthcare provider.
Disclaimer: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before beginning any peptide protocol.
This article is part of the PlexusDx Education Hub. Browse all Blood Testing & Biomarkers education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What are the genetic risk factors for Glaucoma and effective management?
How GCKR Variants Affect Blood Sugar and Insulin